DocPharma: Building the Infrastructure Behind 30-Minute Healthcare Delivery
November 05, 2026 | Thursday | Features
The next transformation in healthcare may not happen at the pharmacy counter, but behind it—in the warehouses, inventory systems and delivery networks that ensure medicines reach patients on time. DocPharma is building a technology-enabled, compliance-first healthcare supply chain that helps pharmacies, hospitals, insurers and wellness brands fulfil orders faster without having to establish their own logistics infrastructure. Its model combines licensed dark stores, AI-powered inventory management, pharmacist-led validation and last-mile delivery to bring healthcare quick commerce closer to reality.
Problem
Healthcare delivery involves complex inventory management, prescription verification, storage requirements and last-mile logistics. Traditional supply chains can create delays and fragmented operations, making rapid medicine fulfilment difficult for digital healthcare businesses. DocPharma aims to address these challenges through an integrated, licensed and technology-driven supply chain.
Product
DocPharma One is the company's integrated technology platform connecting inventory intelligence, warehouse management, order processing, pharmacist validation and last-mile delivery. It supports hyperlocal and 30-minute delivery, same-day and next-day fulfilment, alongside diagnostic sample collection and delivery services.
Proof
DocPharma's website reports more than 24 live dark stores, operations across 10+ cities, over eight lakh orders delivered and a network covering 15,427+ pin codes. It also lists an in-house fleet of 406+ delivery personnel and partnerships with more than 30 healthcare and wellness brands.
People
DocPharma was co-founded by Shashank Rai, Saquib Ali and Sagar Chauhan. Rai brings supply-chain and logistics experience from Tata Steel, Udaan, Shadowfax and Flipkart, while Ali has worked in product and business leadership at Udaan, Toppr and MediBuddy. Chauhan brings technology and engineering experience from Samsung, PayU and other technology businesses.
Purse
On 1 September 2026, DocPharma announced a $2 million (approximately ₹19 crore) Pre-Series A funding round, led by Equentis, with participation from existing investor 100Unicorns, Vinners and angel investors. The company plans to use the capital to establish 100 additional licensed dark stores, strengthen its technology infrastructure and expand its operations to 50 cities.
Plan
DocPharma aims to expand from its existing network into 50 Indian cities by establishing 100 additional licensed dark stores. Its priorities include strengthening DocPharma One, expanding its in-house delivery fleet, improving inventory intelligence and scaling fulfilment services for pharmaceutical, wellness, diagnostics and pet-care businesses.
Why it matters:
DocPharma is addressing an often-overlooked part of digital healthcare: the infrastructure required to deliver medicines and healthcare products reliably. By combining licensed fulfilment centres, pharmacist-led validation and technology-driven logistics, the company is building a backend supply chain that could support the next phase of healthcare quick commerce in India.
FAST FACTS
|
Category
|
Details
|
|
Company
|
DocPharma
|
|
Founded
|
2023
|
|
Headquarters
|
Bengaluru, Karnataka
|
|
Founders
|
Shashank Rai, Saquib Ali and Sagar Chauhan
|
|
Industry
|
HealthTech, PharmaTech, Healthcare Logistics
|
|
Core offering
|
B2B2C healthcare supply-chain infrastructure
|
|
Technology platform
|
DocPharma One
|
|
Key services
|
Dark-store fulfilment, pharmacy logistics, diagnostics and last-mile delivery
|
|
Latest funding
|
$2 million Pre-Series A
|
|
Funding announcement
|
1 September 2026
|
|
Lead investor
|
Equentis
|
|
Other investors
|
100Unicorns, Vinners and angel investors
|
|
Operational network
|
24+ dark stores; 10+ cities
|
|
Reported orders
|
8 lakh+
|
|
Next
|
100 additional dark stores and expansion to 50 cities
|
Disclaimer: This profile is based on publicly available company information, official company disclosures and investor announcements reviewed as of 5 November 2026.
